Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale
Regensburg, Germany
Internal medicine ward in Bavaria
Prüfeninger Str. 86, 93049 Regensburg
About Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale
During the past decade, Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
2011-12-20
2018-06-02
Completed
692
A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma
2014-10-15
2021-10-21
Completed
331
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale
According to Clinical.Site data, the most researched conditions in "Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale" are
"Lymphoma" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale" in a lesser frequency.
Clinical Trials Intervention Types at Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale
Most popular intervention types in "Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (2 trials), "Bendamustine" (1 trials), "Chemotherapy (Induction Period)" (1 trials), "Obinutuzumab" (1 trials) and "Polatuzumab vedotin (Liquid)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale
The vast majority of trials in "Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale" are
2 trials for "All" genders.
Clinical Trials Status at Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale
Currently, there are NaN active trials in "Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinik der Uni Regensburg; Hämatologie/Onkologie, Studienzentrale, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".